<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35184341</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3083</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>36</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the European Academy of Dermatology and Venereology : JEADV</Title>
          <ISOAbbreviation>J Eur Acad Dermatol Venereol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination.</ArticleTitle>
        <Pagination>
          <StartPage>e431</StartPage>
          <EndPage>e433</EndPage>
          <MedlinePgn>e431-e433</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jdv.18024</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mäkilä</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jeskanen</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Butina</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harjama</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0003-3623-2359</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ranki</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-4335-0396</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mälkönen</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kluger</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-5225-8316</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Eur Acad Dermatol Venereol</MedlineTA>
        <NlmUniqueID>9216037</NlmUniqueID>
        <ISSNLinking>0926-9959</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017514" MajorTopicYN="Y">Pityriasis Lichenoides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>20</Day>
          <Hour>20</Hour>
          <Minute>40</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35184341</ArticleId>
        <ArticleId IdType="pmc">PMC9114994</ArticleId>
        <ArticleId IdType="doi">10.1111/jdv.18024</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol
2006; 55: 557–572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17010734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Durusu IN, Gurel G, Tokyol C. Case of Pityriasis Lichenoides chronica in a patient with COVID‐19 infection. Actas Dermosifiliogr
2021. 10.1016/j.ad.2021.09.002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ad.2021.09.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Guelimi R, Salle R, Dousset L
et al. Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology. J Eur Acad Dermatol Venereol
2021; 35: e539–e541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8242387</ArticleId>
            <ArticleId IdType="pubmed">33914975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gianotti R, Restano L, Cutrone M
et al. Papulo‐purpuric dermatitis of childhood: a distinct PLEVA‐like eruption associated to SARS‐CoV‐2 infection. Clinical, histopathological and immunohistochemical study of 10 cases. Pediatr Dermatol
2021; 38: 1185–1190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8646411</ArticleId>
            <ArticleId IdType="pubmed">34463363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sechi A, Pierobon E, Pezzolo E
et al. Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID‐19 vaccine. Clin Exp Dermatol
2021; 47: 437–440. 10.1111/ced.14970
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ced.14970</ArticleId>
            <ArticleId IdType="pmc">PMC8652785</ArticleId>
            <ArticleId IdType="pubmed">34617317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sernicola A, Dybala A, Gomes V
et al. Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID‐19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta‐like eruption. J Eur Acad Dermatol Venereol
2022; 36: e172–e174. 10.1111/jdv.17807
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.17807</ArticleId>
            <ArticleId IdType="pubmed">34751995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Palmén J, Lepistö M, Talve L, Hieta N. Pityriasis lichenoides et varioliformis acuta following COVID‐19 mRNA vaccination. J Eur Acad Dermatol Venereol
2022. 10.1111/jdv.17912
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.17912</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
